From screening to mortality reduction: An overview of the patient journey in ERSPC Rotterdam
Main Authors: | M.J. Roobol, S. Remmers, M.E. Van Slooten-Midderigh, C.G.A.M. Franken-Raab |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320326604 |
Similar Items
-
The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
by: Sebastiaan Remmers, et al.
Published: (2023-05-01) -
Prostate cancer screening in the elderly: A yes or no issue? Long term follow-up data from ERSPC Rotterdam
by: M.J. Roobol, et al.
Published: (2020-07-01) -
Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform
by: Katharina Beyer, et al.
Published: (2022-05-01) -
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
by: Roobol, M, et al.
Published: (2009) -
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.
by: Roobol, M, et al.
Published: (2012)